May 4, 2017 / 11:54 AM / 5 months ago

BRIEF-Genocea biosciences Q1 loss per share $0.48

May 4 (Reuters) - Genocea Biosciences Inc

* Genocea reports first quarter 2017 financial results and positive clinical developments on lead candidate gen-003 in genital herpes

* Q1 loss per share $0.48

* Q1 earnings per share view $-0.54 -- Thomson Reuters I/B/E/S

* Genocea-Expects existing cash, cash equivalents & investments are sufficient to support its operating exp, capex requirements & debt obligations into q1 2018 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below